Safety and efficacy of secondary prophylactic in Patients with severe hemophilia type A and B: A Systematic review and meta-analysis study
Context: Patients with hemophilia recieves coagulation factor replacement for lifetime. In iran, on-demand treatment method is used as standard. Clinical studies have shown significant improvements in clinical and economic outcomes as a result of the use of prophylaxis compared with other therapies....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-05-01
|
Series: | Health Technology Assessment in Action |
Subjects: | |
Online Access: | https://htainaction.tums.ac.ir/index.php/hta/article/view/1 |